Cancer Institute Hospital of JFCR

About Cancer Institute Ariake Hospital

Cancer Institute Hospital of JFCR was established in 1908 and has been a pioneer in cancer treatment in Japan for over 100 years. Since its establishment, it has been committed to the research and development of cutting-edge cancer treatment technology with the philosophy of "overcoming cancer for the benefit of mankind", and has been promoting the advancement of cancer treatment technology in Japan and the world. We have been promoting innovation in the field of cancer treatment technology in Japan and worldwide. Cancer Research Ariake Hospital is currently one of the leading cancer treatment hospitals in Japan, as it is ranked among the top hospitals for all types of cancer treatment by major Japanese magazines. In particular, the hospital is one of the best in the world in terms of cancer treatment procedures for the digestive system.

The hospital currently has 700 beds, 9,188 new patients and 16,017 new admissions in 2013, and an average of over 7,000 surgeries per year, the highest number of oncology treatments in Japan, especially for stomach, breast and bowel cancers.

The surgeons at Cancer Research Ariake Hospital are among the most renowned in Japan and have successfully operated on cases declared inoperable by other hospitals in the treatment of cancers of the digestive system and the head and neck. The hospital is also a leader in Japan in the surgical treatment of almost all cancers, including urological, uterine, ovarian and lung cancers.

With the aim of being "minimally invasive", the hospital uses laparoscopic and thoracoscopic surgery, especially for patients with stomach, colon and lung cancers, which is less invasive and less painful and helps to improve the quality of life of patients. For advanced cancer with lymph node metastasis, not only is the tumour removed, but the lymph node dissection is also carried out, improving the survival rate of patients. Not only do many of the doctors speak English, but the hospital also has a 24-hour telephone translator to facilitate patient consultations. To date, the hospital has treated over 1,000 cancer patients from abroad, including foreigners living in Japan, making it the largest cancer hospital in Japan.

Cancer Research Ariake Hospital is located near Haneda International Airport and the Rinkai sub-centre, which is one of the main venues for the 2020 Tokyo Olympics, and is close to the Tokyo International Convention Centre, Japan's mega convention centre. The hospital is surrounded by green lawns and a park, which makes it a very pleasant climate and a quiet and relaxing environment that maximises patient outcomes.

Treatment targets at Cancer Research Ariake Hospital
Cancers of the digestive system (stomach, colon, oesophagus, liver, bile duct, pancreas), urological system (kidney, bladder, prostate, testicular), gynaecological cancers (cervical, corpus uteri, ovarian), lung, head and neck (oral cavity, pharyngeal head, larynx, salivary cancer, etc.), various bone and soft tissue tumours, blood tumours, breast cancer (simultaneous reconstructive surgery depending on the condition).